On 06 February 2026, Shandong Weigao Group Medical Polymer Company Limited (01066) repurchased 120,000 H shares on the Hong Kong Stock Exchange. The highest repurchase price was HKD 5.30 per share, with a lowest price of HKD 5.26, amounting to HKD 634,000 in total consideration. The repurchased shares were added to treasury shares rather than cancelled, raising the treasury share count from 40,688,400 to 40,808,400.

Following the transaction, there are 4,481,523,924 issued shares excluding treasury shares, keeping the total of 4,522,332,324 shares unchanged. Under the current repurchase mandate authorized on 27 May 2025, up to 451,560,392 shares are permitted for repurchase. As of this latest procedure, the issuer has repurchased an aggregate of 34,160,000 shares, representing approximately 7.5649% of the issuer’s shares authorized under the mandate. A moratorium on any new share issuance or transfer of treasury shares remains in effect until 09 March 2026.